Biolegend, 320111, Alexa Fluor® 488 anti-human FOXP3 Antibody
25tests
Catalog Number: 320111
Send an RFQ.
Category
| Verified Reactivity | Human |
|---|---|
| Reported Reactivity | Baboon, Cynomolgus, Rhesus, Pigtailed Macaque |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | Full-length FOXP3 protein |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA) |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions. |
| Concentration | Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.) |
| Storage & Handling | The FOXP3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | ICFC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by intracellular flow cytometry using our True-Nuclear™ Transcription Factor Staining Protocol. For flow cytometric staining, the suggested use of this reagent is 5 µl per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Excitation Laser | Blue Laser (488 nm) |
|---|
| Application Notes | Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1 and formalin-fixed paraffin-embedded sections1,8,19-20, and Western blotting1. The binding of 206D to FOXP3 can be partially blocked by 259D, but 206D does not show significant blocking effect on 259D binding. NOTE: For flow cytometric staining with this clone, True-Nuclear™ Transcription Factor Buffer Set (Cat. No. 424401) offers improved staining and is highly recommended. |
|---|
| Application References(PubMed link indicates BioLegend citation) | Roncador G, et al. 2005. Eur. J. Immunol. 35:1681.(IHC) Yang ZZ, et al. 2006. Blood 107:3639. Liu W, et al. 2006. J. Exp. Med. 203:1701.PubMed Bollyky PL, et al. 2007. J. Immunol. 179:744. Bell MP, et al. 2007. J. Immunol. 179:1893. Tran DQ, et al. 2007. Blood doi:10.1182/blood-2007-06-094656. PubMed Gao Q,et al.2007.J Clin Oncol.25:2586.(IHC) PubMed Pillai V,et al. 2008. Blood 111:463. PubMed Zheng Y, et al. 2008. J. Immunol. 181:1683. PubMed Zonios DI, et al. 2008.Blood112:287. PubMed Kavanagh B, et al. 2008. Blood. PubMed Nevala WK, et al. 2009. Clin Cancer Res. 15:1931. PubMed Grant J, et al. 2009. Cytometry B Clin Cytom. 76:69. PubMed Nigam P, et al. 2010. J. Immunol. 184:1690. PubMed Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (ICFC) PubMed Hartigan-O'Connor DJ,et al.2007.J Exp Med.204:2679. PubMed Raghaven S, et al. 2009. Ann Rheum Dis. 68:1908. PubMed Hodi FS, et al. 2014. Cancer Immunol Res. 2:632.(IHC) PubMed Sziros E, et al. 2015. Clin Cancer Res. 21:2840.(IHC) PubMed |
|---|
| Product Citations | Nettenstrom L, et al. 2013. J Immunol Methods. 387:81. PubMed Alam A, et al. 2022. Cancer Cell. 40:153. PubMed Pernaa N, et al. 2022. Front Immunol. 13:819929. PubMed Fuhrman C, et al. 2015. J Immunol. 195: 145 - 155. PubMed Nigam P, et al. 2010. J Immunol. 184:1690. PubMed Husseiny MI, et al. 2020. Front Genet. 11:300. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Wang S, et al. 2021. Exp Ther Med. 21:37. PubMed Kelsen J, et al. 2012. Cytokine. 59:403. PubMed Dean JW, et al. 2020. J Autoimmun. 108:102417. PubMed Zheng Y, et al. 2008. J Immunol. 181:1683. PubMed Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed Van Gool F, et al. 2019. Immunity. 50:362. PubMed Wei C, et al. 2016. Cell Death Dis. 7:e2489. PubMed Kubin ME, et al. 2017. Acta Derm Venereol. 97:449. PubMed Liu W, et al. 2006. J Exp Med. 203:1701. PubMed Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed Riese P, et al. 2022. Nat Commun. 13:6894. PubMed Ryba M, et al. 2011. Cytokine. 55:353. PubMed Jin J, et al. 2014. PLoS One. 9:104753. PubMed Nevala W, et al. 2009. Clin Cancer Res. 1.965972222. PubMed |
|---|
| RRID | AB_430882 (BioLegend Cat. No. 320111) AB_430883 (BioLegend Cat. No. 320112) |
|---|
| Structure | Forkhead/winged-helix transcription factor family, approximately 50 kD, contains zinc finger and forkhead domains |
|---|
| Distribution | Nuclear; expressed in T regulatory cells |
|---|
| Function | Transcription factor proposed to be a master regulatory gene in T regulatory cell development and a critical factor for immune homeostasis |
|---|
| Interaction | Interacts with DNA |
|---|
| Cell Type | Tregs |
|---|
| Biology Area | Cell Biology, Immunology, Transcription Factors |
|---|
| Molecular Family | Nuclear Markers |
|---|
| Antigen References | 1. Hori S, et al. 2003. Science 299:1057. 2. Gandhi R, et al. 2010. Nat. Immunol. 11:846. |
|---|
| Regulation | FOXP3 is present at high levels in T regulatory cells, it can also be induced by T cell activation. |
|---|
| Gene ID | 50943 |
|---|
| UniProt | View information about FOXP3 on UniProt.org |
|---|
| Clone | 206D |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Forkhead box protein P3, Scurfin, JM2, IPEX, Zinc finger protein JM2 |
|---|
| Isotype | Mouse IgG1, κ |
|---|